SCHEMBL27484445

SCHEMBL27484445

CC(C(=O)O)c1ccc(Cl)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.53
ADRA2C P18825 1/20 0.53
MAOA P21397 1/20 0.53
ADRA1A P35348 1/20 0.53
DRD3 P35462 1/20 0.53
KCNH2 Q12809 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
HPGD P15428 1/20 0.53
CYP2C19 P33261 1/20 0.53
GABBR2 O75899 1/20 0.49
GABBR1 Q9UBS5 1/20 0.49
DAO P14920 1/20 0.45
F2 P00734 1/20 0.41
PPARA Q07869 1/20 0.40
WRN Q14191 1/20 0.39
UCHL5 Q9Y5K5 2/20 0.38
PTGS2 P35354 4/20 0.37
GSK3B P49841 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27691026 0.86 GABBR2 (0.46) CYP2C9ADRA2CMAOAADRA1ADRD3
SCHEMBL5521104 0.81 GABBR2 (0.46) CYP2C9ADRA2CMAOAADRA1ADRD3
SCHEMBL5926065 0.78 GABBR2 (0.47) CYP2C9ADRA2CMAOAADRA1ADRD3
SCHEMBL23972469 0.78 GABBR2 (0.50) KCNH2CYP3A4CYP2D6HPGDGABBR2
SCHEMBL4632227 0.78 CYP2C9 (0.54) CYP2C9ADRA2CMAOAADRA1ADRD3
SCHEMBL5212433 0.76 GABBR2 (0.53) CYP2C9DRD3CYP1A2CYP3A4CYP2D6
SCHEMBL4392686 0.76 GABBR2 (0.49) HPGDGABBR2GABBR1DAOF2
SCHEMBL1679307 0.76 CYP2C9 (0.53) CYP2C9ADRA2CMAOAADRA1ADRD3
SCHEMBL11791477 0.76 GABBR2 (0.45) GABBR2GABBR1DAOF2PPARA
SCHEMBL7759137 0.74 CYP2C9 (0.65) CYP2C9ADRA2CMAOAADRA1ADRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1201454-A Meta-guanidino, ureido, thioureido or azacyclic aminobenzoic acid derivatives as integrin antagonists SEARLE & CO (US) 1998-12-09 CN disclosed